Changzhou Qianhong Biopharma Co Ltd Financial Flexibility Index
Changzhou Qianhong Biopharma Co Ltd financial flexibility index. Changzhou Qianhong Biopharma Co Ltd (002550) has a Financial Flexibility Index of 0.67x as of September 2025. Free cash flow of CN¥171.92 Million (operating CF CN¥156.34 Million minus capex CN¥15.58 Million) represents 1% of total liabilities (CN¥255.86 Million). See Changzhou Qianhong Biopharma Co Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Changzhou Qianhong Biopharma Co Ltd (2007–2025)
Financial flexibility index of Changzhou Qianhong Biopharma Co Ltd from 2007 to 2025. Historical Financial Flexibility Index trend for Changzhou Qianhong Biopharma Co Ltd across 19 annual periods. Check Changzhou Qianhong Biopharma Co Ltd (002550) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Changzhou Qianhong Biopharma Co Ltd Financial Flexibility Index by Year (2007–2025)
Changzhou Qianhong Biopharma Co Ltd financial flexibility index by year from 2007 to 2025. Year-by-year free cash flow to debt coverage for Changzhou Qianhong Biopharma Co Ltd. For the full cash flow conversion analysis, see 002550 cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.57x | CN¥502.97 Million | CN¥361.36 Million | CN¥320.64 Million | ▼ -18.7% |
| 2024 | 1.93x | CN¥605.35 Million | CN¥514.71 Million | CN¥313.87 Million | ▼ -11.1% |
| 2023 | 2.17x | CN¥633.66 Million | CN¥533.33 Million | CN¥292.17 Million | ▲ +166574.0% |
| 2022 | 0.00x | CN¥-485.32K | CN¥-71.47 Million | CN¥372.53 Million | ▼ -100.3% |
| 2021 | 0.50x | CN¥193.94 Million | CN¥103.56 Million | CN¥390.24 Million | ▼ -49.4% |
| 2020 | 0.98x | CN¥379.81 Million | CN¥317.28 Million | CN¥386.35 Million | ▲ +125.6% |
| 2019 | 0.44x | CN¥262.23 Million | CN¥161.55 Million | CN¥601.65 Million | ▲ +116.3% |
| 2018 | 0.20x | CN¥128.98 Million | CN¥25.45 Million | CN¥640.11 Million | ▼ -32.3% |
| 2017 | 0.30x | CN¥176.15 Million | CN¥88.52 Million | CN¥591.41 Million | ▼ -49.6% |
| 2016 | 0.59x | CN¥359.95 Million | CN¥221.01 Million | CN¥609.33 Million | ▼ -36.6% |
| 2015 | 0.93x | CN¥502.28 Million | CN¥286.50 Million | CN¥538.67 Million | ▼ -51.5% |
| 2014 | 1.92x | CN¥342.54 Million | CN¥252.01 Million | CN¥178.06 Million | ▼ -36.0% |
| 2013 | 3.01x | CN¥288.06 Million | CN¥160.47 Million | CN¥95.77 Million | ▼ -33.3% |
| 2012 | 4.51x | CN¥264.02 Million | CN¥199.82 Million | CN¥58.54 Million | ▲ +126.8% |
| 2011 | 1.99x | CN¥173.13 Million | CN¥146.82 Million | CN¥87.07 Million | ▲ +47.1% |
| 2010 | 1.35x | CN¥182.15 Million | CN¥171.51 Million | CN¥134.75 Million | ▲ +1706.1% |
| 2009 | 0.07x | CN¥21.72 Million | CN¥8.35 Million | CN¥290.19 Million | ▼ -78.9% |
| 2008 | 0.36x | CN¥61.76 Million | CN¥54.36 Million | CN¥173.75 Million | ▼ -36.3% |
| 2007 | 0.56x | CN¥42.96 Million | CN¥35.99 Million | CN¥76.95 Million | — |